Genazzani A R, Petraglia F, Parrini D, Nasi A, Angioni G, Facchinetti F, Facchini V, Volpe A
Am J Obstet Gynecol. 1984 Jan 15;148(2):198-203. doi: 10.1016/s0002-9378(84)80176-3.
Reported are the concentrations of beta-endorphin, beta-lipotropin, and adrenocorticotropic hormone (ACTH) in the amniotic fluid and plasma of 40 healthy pregnant women at different stages of gestation. Moreover, the amniotic fluid levels of the three peptides were evaluated in 20 other pregnant women affected by different pathologic conditions (Cooley's disease, gestosis, diabetes, placental insufficiency, etc.). A silicic acid extraction procedure was performed on the samples. Each extract was subjected to Sephadex G-75 column chromatography, and the two fractions corresponding to beta-lipotropin and beta-endorphin were collected, freeze-dried, and assayed by two specific radioimmunoassays. Levels of ACTH were measured by radioimmunoassay directly on the extracts. Levels of beta-endorphin in amniotic fluid showed the highest values in the first trimester (173 +/- 30 fmol/ml, mean +/- SEM) but were significantly decreased in the second (75.2 +/- 14) and third trimesters (14.3 +/- 1.8). An inverse trend characterized plasma levels of beta-endorphin, which showed a progressive increase from the first trimester to term (10.4 +/- 11.1). Amniotic fluid levels of beta-lipotropin remained stable during the first (48.6 +/- 6.3) and second (54.6 +/- 11.1) trimesters, but decreased significantly in the third trimester (17.9 +/- 2.3). The plasma concentrations of beta-lipotropin showed the highest levels in the first trimester (10.9 +/- 0.9), and decreased significantly at term (8.9 +/- 1.3). Last, amniotic fluid levels of ACTH decreased from 55.3 +/- 4.75 fmol/ml in the first trimester to 12.5 +/- 1.16 in the second trimester, and rose again in the third trimester to 34.4 +/- 6.6 fmol/ml. Plasma levels of ACTH were characterized in the first two trimesters by values twice those recorded for nonpregnant women, and decreased at term to 8.9 +/- 1.4 fmol/ml. In the pregnant patients with fetuses affected by Cooley's disease (second trimester) and in those with edema-proteinuria-hypertension (EPH) gestosis (third trimester), amniotic fluid levels of beta-endorphin, beta-lipotropin, and ACTH were in the same range as those in healthy pregnant women.
报告了40名处于不同妊娠阶段的健康孕妇羊水和血浆中β-内啡肽、β-促脂素和促肾上腺皮质激素(ACTH)的浓度。此外,还评估了另外20名患有不同病理状况(库利氏病、妊娠中毒症、糖尿病、胎盘功能不全等)的孕妇羊水内这三种肽的水平。对样本进行了硅酸萃取程序。每个提取物都经过葡聚糖G - 75柱色谱法处理,收集对应于β-促脂素和β-内啡肽的两个馏分,冻干并通过两种特异性放射免疫测定法进行检测。ACTH水平直接在提取物上通过放射免疫测定法进行测量。羊水中β-内啡肽水平在妊娠早期最高(173±30 fmol/ml,平均值±标准误),但在妊娠中期(75.2±14)和晚期(14.3±1.8)显著下降。β-内啡肽的血浆水平呈现相反趋势,从妊娠早期到足月逐渐升高(10.4±11.1)。β-促脂素的羊水水平在妊娠早期(48.6±6.3)和中期(54.6±11.1)保持稳定,但在妊娠晚期显著下降(17.9±2.3)。β-促脂素的血浆浓度在妊娠早期最高(10.9±0.9),足月时显著下降(8.9±1.3)。最后,ACTH的羊水水平从妊娠早期的55.3±4.75 fmol/ml降至妊娠中期的12.5±1.16,并在妊娠晚期再次升至34.4±6.6 fmol/ml。ACTH的血浆水平在妊娠前两个月的特征是其值是非妊娠妇女记录值 的两倍,足月时降至8.9±1.4 fmol/ml。在患有库利氏病胎儿的孕妇(妊娠中期)和患有水肿 - 蛋白尿 - 高血压(EPH)妊娠中毒症的孕妇(妊娠晚期)中,β-内啡肽、β-促脂素和ACTH的羊水水平与健康孕妇处于相同范围。